HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

mucotrol

an oral polyherbal gel wafer formulation for treatment of oral mucositis

Also Known As:

MF 5232; MF-5232; MF5232

Networked: 1 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Plant Preparations: 622
    - Plant Extracts: 3916
      - mucotrol: 1
Pharmaceutical Preparations
- Plant Extracts: 3916
  - mucotrol: 1

Experts

1.	Mohan, I Krishna: 1 article (01/2005)
2.	Naidu, K Jaganath Rao: 1 article (01/2005)
3.	Naidu, M U R: 1 article (01/2005)
4.	Ramana, G Venkat: 1 article (01/2005)
5.	Rani, P Usha: 1 article (01/2005)
6.	Ratnam, S Venkat: 1 article (01/2005)
7.	Roy, P: 1 article (01/2005)
8.	Sudhavani, T: 1 article (01/2005)
9.	Suresh, P: 1 article (01/2005)

Related Diseases

1.	Mucositis 01/01/2005 - "This pilot study provided positive evidence for the efficacy of MF 5232 therapy in chemoradiation-induced mucositis. " 01/01/2005 - "There was a significant reduction in mean mucositis scores with MF 5232 as follows: WHO (from 3.0 to 1.8), Radiation Therapy Oncology Group (gross score: from 2.8 to 1.8; functional score: from 2.9 to 1.0), and Objective Scoring System (ulceration score: from 7.4 to 4.4; erythema score: from 13.7 to 7.0). " 01/01/2005 - "The primary aim of this study was to compare the clinical efficacy of MF 5232 (Mucotrol), a concentrated oral polyherbal gel wafer formulation, with placebo in the management of chemoradiation-induced mucositis in cancer patients. "
2.	Stomatitis 01/01/2005 - "In this randomised, double-blind, pilot study a total of 30 patients of either sex with chemoradiation-induced oral mucositis were randomised to receive MF 5232 (n = 15) or a matching placebo (n = 15) after food three times a day for 7-10 days. " 01/01/2005 - "A randomised, double-blind, parallel, placebo-controlled study to evaluate the efficacy of MF 5232 (Mucotrol), a concentrated oral gel wafer, in the treatment of oral mucositis."
3.	Erythema 01/01/2005 - "There was a significant reduction in mean mucositis scores with MF 5232 as follows: WHO (from 3.0 to 1.8), Radiation Therapy Oncology Group (gross score: from 2.8 to 1.8; functional score: from 2.9 to 1.0), and Objective Scoring System (ulceration score: from 7.4 to 4.4; erythema score: from 13.7 to 7.0). "
4.	Neoplasms (Cancer) 01/01/2005 - "The primary aim of this study was to compare the clinical efficacy of MF 5232 (Mucotrol), a concentrated oral polyherbal gel wafer formulation, with placebo in the management of chemoradiation-induced mucositis in cancer patients. "

Related Drugs and Biologics

1.	mucotrol

Related Therapies and Procedures

1.	Therapeutics
2.	Radiotherapy